<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39337446</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Role of ACE2 in Neurological Disorders: From Underlying Mechanisms to the Neurological Impact of COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9960</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25189960</ELocationID><Abstract><AbstractText>Angiotensin-converting enzyme 2 (ACE2) has become a hot topic in neuroscience research in recent years, especially in the context of the global COVID-19 pandemic, where its role in neurological diseases has received widespread attention. ACE2, as a multifunctional metalloprotease, not only plays a critical role in the cardiovascular system but also plays an important role in the protection, development, and inflammation regulation of the nervous system. The COVID-19 pandemic further highlights the importance of ACE2 in the nervous system. SARS-CoV-2 enters host cells by binding to ACE2, which may directly or indirectly affect the nervous system, leading to a range of neurological symptoms. This review aims to explore the function of ACE2 in the nervous system as well as its potential impact and therapeutic potential in various neurological diseases, providing a new perspective for the treatment of neurological disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingwen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Sports and Brain Health, School of Physical Education, Henan University, Kaifeng 475004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Xiangrui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Sports and Brain Health, School of Physical Education, Henan University, Kaifeng 475004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1420-1287</Identifier><AffiliationInfo><Affiliation>Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xian</LastName><ForeName>Meiyan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Jianshe</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3560-3392</Identifier><AffiliationInfo><Affiliation>Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Sports and Brain Health, School of Physical Education, Henan University, Kaifeng 475004, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32161143021, 81271410</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>182300410313</GrantID><Agency>Henan Province Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>CJ1205A0240018</GrantID><Agency>Bio-Med Interdisciplinary Innovative Program of Henan University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="Y">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">neurological disorders</Keyword><Keyword MajorTopicYN="N">neuroprotection</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337446</ArticleId><ArticleId IdType="pmc">PMC11431863</ArticleId><ArticleId IdType="doi">10.3390/ijms25189960</ArticleId><ArticleId IdType="pii">ijms25189960</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hernandez-Lopez J.M., Hernandez-Medina C., Medina-Corvalan C., Rodenas M., Francisca A., Perez-Garcia C., Echevarria D., Carratala F., Geijo-Barrientos E., Martinez S. Neuronal progenitors of the dentate gyrus express the SARS-CoV-2 cell receptor during migration in the developing human hippocampus. Cell Mol. Life Sci. 2023;80:140. doi: 10.1007/s00018-023-04787-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-023-04787-8</ArticleId><ArticleId IdType="pmc">PMC10164240</ArticleId><ArticleId IdType="pubmed">37149825</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., Wu Y., Zhang L., Yu Z., Fang M., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8:475–481. doi: 10.1016/S2213-2600(20)30079-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Charnley M., Islam S., Bindra G.K., Engwirda J., Ratcliffe J., Zhou J., Mezzenga R., Hulett M.D., Han K., Berryman J.T., et al. Neurotoxic amyloidogenic peptides in the proteome of SARS-CoV-2: Potential implications for neurological symptoms in COVID-19. Nat. Commun. 2022;13:3387. doi: 10.1038/s41467-022-30932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30932-1</ArticleId><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="pubmed">35697699</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadoro G., Latina V., Stigliano E., Micera A. COVID-19 and Alzheimer’s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future. Cells. 2023;12:2601. doi: 10.3390/cells12222601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12222601</ArticleId><ArticleId IdType="pmc">PMC10670749</ArticleId><ArticleId IdType="pubmed">37998336</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan B.N., Yoo H.J. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) J. Neurol. 2021;268:3059–3071. doi: 10.1007/s00415-021-10406-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10406-y</ArticleId><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G.Y., Wang K., Viveiros A., Kellner M.J., Penninger J.M. Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic. Cell. 2023;186:906–922. doi: 10.1016/j.cell.2023.01.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.01.039</ArticleId><ArticleId IdType="pmc">PMC9892333</ArticleId><ArticleId IdType="pubmed">36787743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zech F., Weber S., Dietenberger H., Zhang L., Noettger S., Volcic M., Bergner T., Read C., Sparrer K.M.J., Barth T.F.E., et al. SARS-CoV-2 inhibition and specific targeting of infected cells by VSV particles carrying the ACE2 receptor. Signal Transduct. Target. Ther. 2023;8:208. doi: 10.1038/s41392-023-01492-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01492-7</ArticleId><ArticleId IdType="pmc">PMC10200011</ArticleId><ArticleId IdType="pubmed">37211548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H., Stein D.A., Hardes K., Eickmann M., Dolnik O., et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci. Alliance. 2020;3:9. doi: 10.26508/lsa.202000786.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202000786</ArticleId><ArticleId IdType="pmc">PMC7383062</ArticleId><ArticleId IdType="pubmed">32703818</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Chen P., Wang J., Feng J., Zhou H., Li X., Zhong W., Hao P. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci. China Life Sci. 2020;63:457–460. doi: 10.1007/s11427-020-1637-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-020-1637-5</ArticleId><ArticleId IdType="pmc">PMC7089049</ArticleId><ArticleId IdType="pubmed">32009228</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z., Fan H., Bao X., Wu J. Angiotensin-Converting Enzyme 2 Activation Is Not a Common Feature of Angiotensin-Converting Enzyme Inhibitory Peptides. J. Agric. Food Chem. 2023;71:8867–8876. doi: 10.1021/acs.jafc.2c04211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.2c04211</ArticleId><ArticleId IdType="pubmed">37272779</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquez A., Wysocki J., Pandit J., Batlle D. An update on ACE2 amplification and its therapeutic potential. Acta Physiol. 2021;231:e13513. doi: 10.1111/apha.13513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.13513</ArticleId><ArticleId IdType="pmc">PMC7267104</ArticleId><ArticleId IdType="pubmed">32469114</ArticleId></ArticleIdList></Reference><Reference><Citation>Danser A.H.J., Epstein M., Batlle D. Renin-Angiotensin System Blockers and the COVID-19 Pandemic At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Hypertension. 2020;75:1382–1385. doi: 10.1161/HYPERTENSIONAHA.120.15082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15082</ArticleId><ArticleId IdType="pmc">PMC7225046</ArticleId><ArticleId IdType="pubmed">32208987</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell M.C. Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment. Circ. Res. 2023;132:1320–1337. doi: 10.1161/CIRCRESAHA.123.321883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.123.321883</ArticleId><ArticleId IdType="pmc">PMC10171311</ArticleId><ArticleId IdType="pubmed">37167353</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang R., Yang M., Cui C., Wang C., Zhang W., Geng C., Han W., Jiang P. Activation of angiotensin-converting enzyme 2/angiotensin (1-7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling. Aging Cell. 2021;20:e13480. doi: 10.1111/acel.13480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13480</ArticleId><ArticleId IdType="pmc">PMC8520723</ArticleId><ArticleId IdType="pubmed">34529881</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi S., Chittimalli K., Jahan J., Vasam G., Jarajapu Y.P. ACE2/ACE imbalance and impaired vasoreparative functions of stem/progenitor cells in aging. Geroscience. 2021;43:1423–1436. doi: 10.1007/s11357-020-00306-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00306-w</ArticleId><ArticleId IdType="pmc">PMC7694587</ArticleId><ArticleId IdType="pubmed">33247425</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Chen F., Gao J., Lei M., Wang D., Jin X., Guo Y., Shan L., Chen X. Comprehensive landscape of the renin-angiotensin system in Pan-cancer: A potential downstream mediated mechanism of SARS-CoV-2. Int. J. Biol. Sci. 2021;17:3795–3817. doi: 10.7150/ijbs.53312.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.53312</ArticleId><ArticleId IdType="pmc">PMC8495399</ArticleId><ArticleId IdType="pubmed">34671200</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T., Murakami M. COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome. Immunity. 2020;52:731–733. doi: 10.1016/j.immuni.2020.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7175868</ArticleId><ArticleId IdType="pubmed">32325025</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W., Huang N., Becavin C., Berg M., Queen R., Litvinukova M., Talavera-López C., Maatz H., Reichart D., Sampaziotis F., et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020;26:681–687. doi: 10.1038/s41591-020-0868-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur N., Oskotsky B., Butte A.J., Hu Z. Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patients. Genome Biol. 2022;23:15. doi: 10.1186/s13059-021-02589-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-021-02589-4</ArticleId><ArticleId IdType="pmc">PMC8743438</ArticleId><ArticleId IdType="pubmed">35012625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez V.S., Zetter M.A., Guerra E.C., Hernández-Araiza I., Karuzin N., Hernández-Pérez O.R., Eiden L.E., Zhang L. ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations. Exp. Neurol. 2021;345:113837. doi: 10.1016/j.expneurol.2021.113837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2021.113837</ArticleId><ArticleId IdType="pmc">PMC8361001</ArticleId><ArticleId IdType="pubmed">34400158</ArticleId></ArticleIdList></Reference><Reference><Citation>Klempin F., Mosienko V., Matthes S., Villela D.C., Todiras M., Penninger J.M., Bader M., Santos R.A.S., Alenina N. Depletion of angiotensin-converting enzyme 2 reduces brain serotonin and impairs the running-induced neurogenic response. Cell Mol. Life Sci. 2018;75:3625–3634. doi: 10.1007/s00018-018-2815-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-018-2815-y</ArticleId><ArticleId IdType="pmc">PMC7079801</ArticleId><ArticleId IdType="pubmed">29679094</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Archie S.R., Ghanwatkar Y., Sharma S., Nozohouri S., Burks E., Mdzinarishvili A., Liu Z., Abbruscato T.J. Potential role of astrocyte angiotensin converting enzyme 2 in the neural transmission of COVID-19 and a neuroinflammatory state induced by smoking and vaping. Fluids Barriers CNS. 2022;19:46. doi: 10.1186/s12987-022-00339-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-022-00339-7</ArticleId><ArticleId IdType="pmc">PMC9171490</ArticleId><ArticleId IdType="pubmed">35672716</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarleri J., Delpino M.V. SARS-CoV-2 interacts with renin-angiotensin system: Impact on the central nervous system in elderly patients. Geroscience. 2022;44:547–565. doi: 10.1007/s11357-022-00528-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-022-00528-0</ArticleId><ArticleId IdType="pmc">PMC8853071</ArticleId><ArticleId IdType="pubmed">35157210</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney M.D., Ayyadurai S., Zlokovic B.V. Pericytes of the neurovascular unit: Key functions and signaling pathways. Nat. Neurosci. 2016;19:771–783. doi: 10.1038/nn.4288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4288</ArticleId><ArticleId IdType="pmc">PMC5745011</ArticleId><ArticleId IdType="pubmed">27227366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko N., Satta S., Komuro Y., Muthukrishnan S.D., Kakarla V., Guo L., An J., Elahi F., Kornblum H.I., Liebeskind D.S., et al. Flow-Mediated Susceptibility and Molecular Response of Cerebral Endothelia to SARS-CoV-2 Infection. Stroke. 2021;52:260–270. doi: 10.1161/STROKEAHA.120.032764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.032764</ArticleId><ArticleId IdType="pmc">PMC7769899</ArticleId><ArticleId IdType="pubmed">33161843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran A.K., Das S., Joseph A. Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review. Curr. Neuropharmacol. 2021;19:1688–1700. doi: 10.2174/1570159X19666210113154342.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X19666210113154342</ArticleId><ArticleId IdType="pmc">PMC8977634</ArticleId><ArticleId IdType="pubmed">33441073</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Shao L., Lin Z., Long Q.X., Yuan H., Cai L., Jiang G., Guo X., Yang R., Zhang Z., et al. APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients. Signal Transduct. Target. Ther. 2022;7:261. doi: 10.1038/s41392-022-01118-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-01118-4</ArticleId><ArticleId IdType="pmc">PMC9340718</ArticleId><ArticleId IdType="pubmed">35915083</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;183:16–27.e11. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian J., Li Z. Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. Acta Pharm. Sin. B. 2021;11:1–12. doi: 10.1016/j.apsb.2020.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2020.10.006</ArticleId><ArticleId IdType="pmc">PMC7553008</ArticleId><ArticleId IdType="pubmed">33072500</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W.H., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–454. doi: 10.1038/nature02145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin-converting enzyme—Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000;275:33238–33243. doi: 10.1074/jbc.M002615200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M002615200</ArticleId><ArticleId IdType="pubmed">10924499</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ. Res. 2000;87:E1–E9. doi: 10.1161/01.RES.87.5.e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 2002;277:14838–14843. doi: 10.1074/jbc.M200581200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200581200</ArticleId><ArticleId IdType="pubmed">11815627</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K.M., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2. Circ. Res. 2020;126:1456–1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L., Lely A.T., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631–637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U., Ding M., Tan G., Zhakparov D., Peng Y., Wawrzyniak P., Wang M., Li S., Morita H., Altunbulakli C., et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75:2829–2845. doi: 10.1111/all.14429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14429</ArticleId><ArticleId IdType="pmc">PMC7300910</ArticleId><ArticleId IdType="pubmed">32496587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper N.M., Lambert D.W., Turner A.J. Discovery and characterization of ACE2—A 20-year journey of surprises from vasopeptidase to COVID-19. Clin. Sci. 2020;134:2489–2501. doi: 10.1042/CS20200476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200476</ArticleId><ArticleId IdType="pubmed">32990314</ArticleId></ArticleIdList></Reference><Reference><Citation>Oz M., Lorke D.E. Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury. Biomed. Pharmacother. 2021;136:111193. doi: 10.1016/j.biopha.2020.111193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.111193</ArticleId><ArticleId IdType="pmc">PMC7836742</ArticleId><ArticleId IdType="pubmed">33461019</ArticleId></ArticleIdList></Reference><Reference><Citation>Mughal A., O’Rourke S.T. Vascular effects of apelin: Mechanisms and therapeutic potential. Pharmacol. Ther. 2018;190:139–147. doi: 10.1016/j.pharmthera.2018.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2018.05.013</ArticleId><ArticleId IdType="pmc">PMC6165679</ArticleId><ArticleId IdType="pubmed">29807055</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., McKinnie S.M., Farhan M., Paul M., McDonald T., McLean B., Llorens-Cortes C., Hazra S., Murray A.G., Vederas J.C., et al. Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System. Hypertension. 2016;68:365–377. doi: 10.1161/HYPERTENSIONAHA.115.06892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.115.06892</ArticleId><ArticleId IdType="pubmed">27217402</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo F., Daniele A., Amato F., Pastore L., Matera M.G., Cazzola M., Castaldo G., Bianco A. ACE2: The Major Cell Entry Receptor for SARS-CoV-2. Lung. 2020;198:867–877. doi: 10.1007/s00408-020-00408-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-020-00408-4</ArticleId><ArticleId IdType="pmc">PMC7653219</ArticleId><ArticleId IdType="pubmed">33170317</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Veerdonk F.L., Netea M.G., van Deuren M., van der Meer J.W., de Mast Q., Brüggemann R.J., van der Hoeven H. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. eLife. 2020;9:e57555. doi: 10.7554/eLife.57555.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57555</ArticleId><ArticleId IdType="pmc">PMC7213974</ArticleId><ArticleId IdType="pubmed">32338605</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos R.A.S., Taccone F.S., Annoni F. Renin-Angiotensin System Modulation in Adults With COVID-19. JAMA. 2023;330:663–664. doi: 10.1001/jama.2023.10783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.10783</ArticleId><ArticleId IdType="pubmed">37581678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye D., Cruz-Lopez E.O., Tu H.C., Zlatev I., Danser A.H.J. Targeting Angiotensinogen With N-Acetylgalactosamine-Conjugated Small Interfering RNA to Reduce Blood Pressure. Arterioscler. Thromb. Vasc. Biol. 2023;43:2256–2264. doi: 10.1161/ATVBAHA.123.319897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.123.319897</ArticleId><ArticleId IdType="pmc">PMC10659251</ArticleId><ArticleId IdType="pubmed">37855126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepúlveda-Fragoso V., Alexandre-Santos B., Salles A.C.P., Proença A.B., de Paula Alves A.P., Vázquez-Carrera M., Nóbrega A.C.L., Frantz E.D.C., Magliano D.C. Crosstalk between the renin-angiotensin system and the endoplasmic reticulum stress in the cardiovascular system: Lessons learned so far. Life Sci. 2021;284:119919. doi: 10.1016/j.lfs.2021.119919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119919</ArticleId><ArticleId IdType="pubmed">34480931</ArticleId></ArticleIdList></Reference><Reference><Citation>Verano-Braga T., Martins A.L.V., Motta-Santos D., Campagnole-Santos M.J., Santos R.A.S. ACE2 in the renin-angiotensin system. Clin. Sci. 2020;134:3063–3078. doi: 10.1042/CS20200478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200478</ArticleId><ArticleId IdType="pubmed">33264412</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriakose J., Montezano A.C., Touyz R.M. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: Vasoprotection to COVID-19-associated vascular disease. Clin. Sci. 2021;135:387–407. doi: 10.1042/CS20200480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200480</ArticleId><ArticleId IdType="pmc">PMC7846970</ArticleId><ArticleId IdType="pubmed">33511992</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross S., Jahn C., Cushman S., Bär C., Thum T. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications. J. Mol. Cell Cardiol. 2020;144:47–53. doi: 10.1016/j.yjmcc.2020.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7191280</ArticleId><ArticleId IdType="pubmed">32360703</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Arif G., Farhat A., Khazaal S., Annweiler C., Kovacic H., Wu Y., Cao Z., Fajloun Z., Khattar Z.A., Sabatier J.M. The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19. Molecules. 2021;26:6945. doi: 10.3390/molecules26226945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26226945</ArticleId><ArticleId IdType="pmc">PMC8622307</ArticleId><ArticleId IdType="pubmed">34834033</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A., Li F. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221–224. doi: 10.1038/s41586-020-2179-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2179-y</ArticleId><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C.B., Farzan M., Chen B., Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 2022;23:3–20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang F., Bai L., Dong J., Hu X., Wang J., Paulo J.A., Xiong Y., Liang X., Sun Y., Chen Y., et al. USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice. Sci. Transl. Med. 2023;15:eadh7668. doi: 10.1126/scitranslmed.adh7668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.adh7668</ArticleId><ArticleId IdType="pmc">PMC10787358</ArticleId><ArticleId IdType="pubmed">38055802</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuaid C., Brady M., Deane R. SARS-CoV-2: Is there neuroinvasion? Fluids Barriers CNS. 2021;18:32. doi: 10.1186/s12987-021-00267-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-021-00267-y</ArticleId><ArticleId IdType="pmc">PMC8278192</ArticleId><ArticleId IdType="pubmed">34261487</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui H., Su S., Cao Y., Ma C., Qiu W. The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer’s Disease Pathology. Front. Cell Dev. Biol. 2021;9:684874. doi: 10.3389/fcell.2021.684874.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.684874</ArticleId><ArticleId IdType="pmc">PMC8267059</ArticleId><ArticleId IdType="pubmed">34249938</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J.X., Lazartigues E. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus. Cell. Mol. Neurobiol. 2022;42:305–309. doi: 10.1007/s10571-020-00915-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00915-1</ArticleId><ArticleId IdType="pmc">PMC7334623</ArticleId><ArticleId IdType="pubmed">32623546</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Huang H.Y., Wang H.D., Gao C.C., Liang H., Deng C.L., Zhao X., Han Y.L., Zhou M.L. Restoration of Brain Angiotensin-Converting Enzyme 2 Alleviates Neurological Deficits after Severe Traumatic Brain Injury via Mitigation of Pyroptosis and Apoptosis. J. Neurotrauma. 2022;39:423–434. doi: 10.1089/neu.2021.0382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2021.0382</ArticleId><ArticleId IdType="pubmed">34861788</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela R., Rodriguez-Perez A.I., Costa-Besada M.A., Rivas-Santisteban R., Garrido-Gil P., Lopez-Lopez A., Navarro G., Lanciego J.L., Franco R., Labandeira-Garcia J.L. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria. Redox Biol. 2021;46:102078. doi: 10.1016/j.redox.2021.102078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102078</ArticleId><ArticleId IdType="pmc">PMC8346680</ArticleId><ArticleId IdType="pubmed">34333284</ArticleId></ArticleIdList></Reference><Reference><Citation>Reveret L., Leclerc M., Emond V., Tremblay C., Loiselle A., Bourassa P., Bennett D.A., Hébert S.S., Calon F. Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer’s disease. Acta Neuropathol. Commun. 2023;11:159. doi: 10.1186/s40478-023-01647-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-023-01647-1</ArticleId><ArticleId IdType="pmc">PMC10544218</ArticleId><ArticleId IdType="pubmed">37784209</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong W., Montano M., Corley M.J., Helmy E., Kobayashi H., Kinisu M., Suryawanshi R., Luo X., Royer L.A., Roan N.R., et al. Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons. mBio. 2022;13:e0230822. doi: 10.1128/mbio.02308-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.02308-22</ArticleId><ArticleId IdType="pmc">PMC9765283</ArticleId><ArticleId IdType="pubmed">36314791</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitale-Cross L., Szalayova I., Scoggins A., Palkovits M., Mezey E. SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: Clinical implications. Ebiomedicine. 2022;78:103981. doi: 10.1016/j.ebiom.2022.103981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103981</ArticleId><ArticleId IdType="pmc">PMC8978584</ArticleId><ArticleId IdType="pubmed">35390636</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa L.C., Goncalves T.L., de Araujo L.P., Rosario L.V.O., Ferrer V.P. Endothelial cells and SARS-CoV-2: An intimate relationship. Vascul. Pharmacol. 2021;137:106829. doi: 10.1016/j.vph.2021.106829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2021.106829</ArticleId><ArticleId IdType="pmc">PMC7834309</ArticleId><ArticleId IdType="pubmed">33422689</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Wan T.T., Li J.X., Xiao X., Liu L., Li H.H., Guo S.B. ACE2 Rescues Sepsis-Associated Encephalopathy by Reducing Inflammation, Oxidative Stress, and Neuronal Apoptosis via the Nrf2/Sestrin2 Signaling Pathway. Mol. Neurobiol. 2024 doi: 10.1007/s12035-024-04063-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-024-04063-1</ArticleId><ArticleId IdType="pubmed">38532242</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Li J., Sun L., Zhu C., Wei J. The role of ACE2 in RAS axis on microglia activation in Parkinson’s disease. Neuroscience. 2024;553:128–144. doi: 10.1016/j.neuroscience.2024.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2024.06.024</ArticleId><ArticleId IdType="pubmed">38986737</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Qahtani Z., Al-Kuraishy H.M., Al-Gareeb A.I., Albuhadily A.K., Ali N.H., Alexiou A., Papadakis M., Saad H.M., Batiha G.E. The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat? J. Cell. Mol. Med. 2024;28:e18495. doi: 10.1111/jcmm.18495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.18495</ArticleId><ArticleId IdType="pmc">PMC11187740</ArticleId><ArticleId IdType="pubmed">38899551</ArticleId></ArticleIdList></Reference><Reference><Citation>Achar A., Ghosh C. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance. Cells. 2020;9:2360. doi: 10.3390/cells9112360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112360</ArticleId><ArticleId IdType="pmc">PMC7692725</ArticleId><ArticleId IdType="pubmed">33120941</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C.E., Miners J.S., Piva G., Willis C.L., Heard D.M., Kidd E.J., Good M.A., Kehoe P.G. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease. Acta Neuropathol. 2020;139:485–502. doi: 10.1007/s00401-019-02098-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02098-6</ArticleId><ArticleId IdType="pmc">PMC7035243</ArticleId><ArticleId IdType="pubmed">31982938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel A.S., Abdelkader N.F., Abd El-Rahman S.S., Emara M., Zaki H.F., Khattab M.M. Stimulation of ACE2/ANG(1-7)/Mas Axis by Diminazene Ameliorates Alzheimer’s Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway. Mol. Neurobiol. 2018;55:8188–8202. doi: 10.1007/s12035-018-0966-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-0966-3</ArticleId><ArticleId IdType="pubmed">29516284</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon C.L., Hurley E.M., Muniz Perez A., Estrada M., Lodge D.J., Hsieh J. Prenatal SARS-CoV-2 infection results in neurodevelopmental and behavioral outcomes in mice. JCI Insight. 2024;9:e179068. doi: 10.1172/jci.insight.179068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.179068</ArticleId><ArticleId IdType="pmc">PMC11383367</ArticleId><ArticleId IdType="pubmed">38781563</ArticleId></ArticleIdList></Reference><Reference><Citation>Graff-Radford J., Yong K.X.X., Apostolova L.G., Bouwman F.H., Carrillo M., Dickerson B.C., Rabinovici G.D., Schott J.M., Jones D.T., Murray M.E. New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol. 2021;20:222–234. doi: 10.1016/S1474-4422(20)30440-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30440-3</ArticleId><ArticleId IdType="pmc">PMC8056394</ArticleId><ArticleId IdType="pubmed">33609479</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.A., Cruz G., Syty M.D., Wang F., Wang X., Duan A., Halterman M., Xiong Q., Palop J.J., Ge S. Neural circuit mechanisms underlying aberrantly prolonged functional hyperemia in young Alzheimer’s disease mice. Mol. Psychiatry. 2024 doi: 10.1038/s41380-024-02680-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-024-02680-9</ArticleId><ArticleId IdType="pubmed">39043843</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Wang J.J., Ma X.T., Wang W., Zhao B., Chen Y., Chen C., Bihl J.C. ACE2-EPC-EXs protect ageing ECs against hypoxia/reoxygenation-induced injury through the miR-18a/Nox2/ROS pathway. J. Cell. Mol. Med. 2018;22:1873–1882. doi: 10.1111/jcmm.13471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13471</ArticleId><ArticleId IdType="pmc">PMC5824419</ArticleId><ArticleId IdType="pubmed">29363860</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehoe P.G., Wong S., Al Mulhim N., Palmer L.E., Miners J.S. Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology. Alzheimers Res. Ther. 2016;8:50. doi: 10.1186/s13195-016-0217-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-016-0217-7</ArticleId><ArticleId IdType="pmc">PMC5123239</ArticleId><ArticleId IdType="pubmed">27884212</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLachlan R., Kehoe P.G., Miners J.S. Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer’s Disease. J. Gerontol. A Biol. Sci. Med. Sci. 2022;77:1775–1783. doi: 10.1093/gerona/glac083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glac083</ArticleId><ArticleId IdType="pmc">PMC9434468</ArticleId><ArticleId IdType="pubmed">35396835</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan R., Xue X., Zhang Q.Q., Wang S.Y., Gong P.Y., E Y., Jiang T., Zhang Y.D. ACE2 activator diminazene aceturate ameliorates Alzheimer’s disease-like neuropathology and rescues cognitive impairment in SAMP8 mice. Aging. 2020;12:14819–14829. doi: 10.18632/aging.103544.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103544</ArticleId><ArticleId IdType="pmc">PMC7425432</ArticleId><ArticleId IdType="pubmed">32701063</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Deng Y., Ge P., Peng Q., Soufiany I., Zhu L., Duan R. Diminazene Ameliorates Neuroinflammation by Suppression of Astrocytic miRNA-224-5p/NLRP3 Axis in Alzheimer’s Disease Model. J. Inflamm. Res. 2023;16:1639–1652. doi: 10.2147/JIR.S401385.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S401385</ArticleId><ArticleId IdType="pmc">PMC10120828</ArticleId><ArticleId IdType="pubmed">37092127</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Zhang Y., Zhang L., Qin C. Overexpression of ACE2 ameliorates Aβ-induced blood-brain barrier damage and angiogenesis by inhibiting NF-κB/VEGF/VEGFR2 pathway. Animal Model. Exp. Med. 2023;6:237–244. doi: 10.1002/ame2.12324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ame2.12324</ArticleId><ArticleId IdType="pmc">PMC10272905</ArticleId><ArticleId IdType="pubmed">37183346</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolosa E., Garrido A., Scholz S.W., Poewe W. Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol. 2021;20:385–397. doi: 10.1016/S1474-4422(21)00030-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00030-2</ArticleId><ArticleId IdType="pmc">PMC8185633</ArticleId><ArticleId IdType="pubmed">33894193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye H., Robak L.A., Yu M., Cykowski M., Shulman J.M. Genetics and Pathogenesis of Parkinson’s Syndrome. Annu. Rev. Pathol. 2023;18:95–121. doi: 10.1146/annurev-pathmechdis-031521-034145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-031521-034145</ArticleId><ArticleId IdType="pmc">PMC10290758</ArticleId><ArticleId IdType="pubmed">36100231</ArticleId></ArticleIdList></Reference><Reference><Citation>Labandeira C.M., Pedrosa M.A., Quijano A., Valenzuela R., Garrido-Gil P., Sanchez-Andrade M., Suarez-Quintanilla J.A., Rodriguez-Perez A.I., Labandeira-Garcia J.L. Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson’s disease. NPJ Parkinsons Dis. 2022;8:76. doi: 10.1038/s41531-022-00340-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-022-00340-9</ArticleId><ArticleId IdType="pmc">PMC9198025</ArticleId><ArticleId IdType="pubmed">35701430</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Wu H., Sun L., Wei J. Role of Inflammation in the Development of COVID-19 to Parkinson’s Disease. J. Inflamm. Res. 2024;17:3259–3282. doi: 10.2147/JIR.S460161.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S460161</ArticleId><ArticleId IdType="pmc">PMC11127656</ArticleId><ArticleId IdType="pubmed">38800597</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Tiwari V., Tiwari P., Parul, Mishra A., Hanif K., Shukla S. Angiotensin-Converting Enzyme 2 Activation Mitigates Behavioral Deficits and Neuroinflammatory Burden in 6-OHDA Induced Experimental Models of Parkinson’s Disease. ACS Chem. Neurosci. 2022;13:1491–1504. doi: 10.1021/acschemneuro.1c00797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00797</ArticleId><ArticleId IdType="pubmed">35533351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajoolabady A., Wang S., Kroemer G., Penninger J.M., Uversky V.N., Pratico D., Henninger N., Reiter R.J., Bruno A., Joshipura K., et al. Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics. Pharmacol. Ther. 2021;225:107848. doi: 10.1016/j.pharmthera.2021.107848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2021.107848</ArticleId><ArticleId IdType="pmc">PMC8263472</ArticleId><ArticleId IdType="pubmed">33823204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik P., Kaushik M., Parveen S., Tabassum H., Parvez S. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic. Mol. Neurobiol. 2020;57:4921–4928. doi: 10.1007/s12035-020-02072-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02072-4</ArticleId><ArticleId IdType="pmc">PMC7434850</ArticleId><ArticleId IdType="pubmed">32813238</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Ren X.S., Zhao M.X., Zhou B., Han Y. Angiotensin-(1-7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways. Sci. Rep. 2016;6:34621. doi: 10.1038/srep34621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34621</ArticleId><ArticleId IdType="pmc">PMC5043354</ArticleId><ArticleId IdType="pubmed">27687768</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J.L., Li G.Z., Chen S.Z., Wang J.J., Olson J.E., Xia H.J., Lazartigues E., Zhu Y.L., Chen Y.F. Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence. CNS Neurosci. Ther. 2014;20:452–459. doi: 10.1111/cns.12233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12233</ArticleId><ArticleId IdType="pmc">PMC4840841</ArticleId><ArticleId IdType="pubmed">24581232</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M., Salie H., Tanevski J., Killmer S., Lago M.S., Schlaak A.E., Mayer L., Matschke J., Püschel K., Fitzek A., et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54:1594–1610 e1511. doi: 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Lu J., Shao A., Zhang J.H., Zhang J. Glial Cells: Role of the Immune Response in Ischemic Stroke. Front. Immunol. 2020;11:294. doi: 10.3389/fimmu.2020.00294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00294</ArticleId><ArticleId IdType="pmc">PMC7055422</ArticleId><ArticleId IdType="pubmed">32174916</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennion D.M., Jones C.H., Donnangelo L.L., Graham J.T., Isenberg J.D., Dang A.N., Rodriguez V., Sinisterra R.D.M., Sousa F.B., Santos R.A.S., et al. Neuroprotection by post-stroke administration of an oral formulation of angiotensin-(1-7) in ischaemic stroke. Exp. Physiol. 2018;103:916–923. doi: 10.1113/EP086957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP086957</ArticleId><ArticleId IdType="pubmed">29663576</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., de Kloet A.D., Pati D., Hiller H., Smith J.A., Pioquinto D.J., Ludin J.A., Oh S.P., Katovich M.J., Frazier C.J., et al. Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors. Neuropharmacology. 2016;105:114–123. doi: 10.1016/j.neuropharm.2015.12.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.12.026</ArticleId><ArticleId IdType="pmc">PMC4873386</ArticleId><ArticleId IdType="pubmed">26767952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L.A., de Kloet A.D., Smeltzer M.D., Cahill K.M., Hiller H., Bruce E.B., Pioquinto D.J., Ludin J.A., Katovich M.J., Raizada M.K., et al. Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice. Neuropharmacology. 2018;133:85–93. doi: 10.1016/j.neuropharm.2018.01.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2018.01.025</ArticleId><ArticleId IdType="pmc">PMC5858993</ArticleId><ArticleId IdType="pubmed">29360543</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kloet A.D., Cahill K.M., Scott K.A., Krause E.G. Overexpression of angiotensin converting enzyme 2 reduces anxiety-like behavior in female mice. Physiol. Behav. 2020;224:113002. doi: 10.1016/j.physbeh.2020.113002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2020.113002</ArticleId><ArticleId IdType="pmc">PMC7503770</ArticleId><ArticleId IdType="pubmed">32525008</ArticleId></ArticleIdList></Reference><Reference><Citation>Yüce M., Filiztekin E., Özkaya K.G. COVID-19 diagnosis—A review of current methods. Biosens. Bioelectron. 2021;172:112752. doi: 10.1016/j.bios.2020.112752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2020.112752</ArticleId><ArticleId IdType="pmc">PMC7584564</ArticleId><ArticleId IdType="pubmed">33126180</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Kim T.W., Han Y., Nair M.S., Harschnitz O., Zhu J., Wang P., Koo S.Y., Lacko L.A., Chandar V., et al. SARS-CoV-2 infection causes dopaminergic neuron senescence. Cell Stem Cell. 2024;31:196–211 e196. doi: 10.1016/j.stem.2023.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2023.12.012</ArticleId><ArticleId IdType="pmc">PMC10843182</ArticleId><ArticleId IdType="pubmed">38237586</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Lin D., Xu X., Liu X., Zhang J., Huang K., Wang F., Liu J., Zhang Z., Tao E. Central nervous system complications in SARS-CoV-2-infected patients. J. Neurol. 2023;270:4617–4631. doi: 10.1007/s00415-023-11912-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-023-11912-x</ArticleId><ArticleId IdType="pmc">PMC10511589</ArticleId><ArticleId IdType="pubmed">37573554</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484–3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez-Mámol R., Giordano-Santini R., Kaulich E., Cho A.N., Przybyla M., Riyadh M.A., Robinson E., Chew K.Y., Amor R., Meunier F.A., et al. SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity. Sci. Adv. 2023;9:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10246911</ArticleId><ArticleId IdType="pubmed">37285437</ArticleId></ArticleIdList></Reference><Reference><Citation>Adesse D., Gladulich L., Alvarez-Rosa L., Siqueira M., Marcos A.C., Heider M., Motta C.S., Torices S., Toborek M., Stipursky J. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: Impacts on neurological symptoms of COVID-19. Fluids Barriers Cns. 2022;19:63. doi: 10.1186/s12987-022-00357-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-022-00357-5</ArticleId><ArticleId IdType="pmc">PMC9386676</ArticleId><ArticleId IdType="pubmed">35982454</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L., Albecka A., Mallery D.L., Kellner M.J., Paul D., Carter A.P., James L.C., Lancaster M.A. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids. Cell Stem Cell. 2020;27:951–961.e955. doi: 10.1016/j.stem.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh E.V., Wolff M., Moore P.A., Theken K.N., Daniell H. A Pair of “ACEs”. J. Dent. Res. 2022;101:5–10. doi: 10.1177/00220345211047510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00220345211047510</ArticleId><ArticleId IdType="pmc">PMC8721725</ArticleId><ArticleId IdType="pubmed">34689655</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo P., Mur I., Pomar V., Casademont J., de Benito N. The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19) EBioMedicine. 2020;58:102887. doi: 10.1016/j.ebiom.2020.102887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102887</ArticleId><ArticleId IdType="pmc">PMC7387269</ArticleId><ArticleId IdType="pubmed">32736307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Zhao H., An Y. ACE2 Shedding and the Role in COVID-19. Front. Cell. Infect. Microbiol. 2021;11:789180. doi: 10.3389/fcimb.2021.789180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.789180</ArticleId><ArticleId IdType="pmc">PMC8795668</ArticleId><ArticleId IdType="pubmed">35096642</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Penninger J.M., Li Y., Zhong N., Slutsky A.S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020;46:586–590. doi: 10.1007/s00134-020-05985-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05985-9</ArticleId><ArticleId IdType="pmc">PMC7079879</ArticleId><ArticleId IdType="pubmed">32125455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.W., Chuang H.C., Tan T.H. ACE2 in chronic disease and COVID-19: Gene regulation and post-translational modification. J. Biomed. Sci. 2023;30:71. doi: 10.1186/s12929-023-00965-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-023-00965-9</ArticleId><ArticleId IdType="pmc">PMC10464117</ArticleId><ArticleId IdType="pubmed">37608279</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteil V., Kwon H., Prado P., Hagelkrüys A., Wimmer R.A., Stahl M., Leopoldi A., Garreta E., Hurtado Del Pozo C., Prosper F., et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020;181:905–913.e907. doi: 10.1016/j.cell.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7181998</ArticleId><ArticleId IdType="pubmed">32333836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Zhou L., Bao L.L., Liu J., Zhu H., Lv Q., Liu R., Chen W., Tong W., Wei Q., et al. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct. Target. Ther. 2021;6:337. doi: 10.1038/s41392-021-00719-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00719-9</ArticleId><ArticleId IdType="pmc">PMC8419672</ArticleId><ArticleId IdType="pubmed">34489403</ArticleId></ArticleIdList></Reference><Reference><Citation>Welcome M.O., Mastorakis N.E. Neuropathophysiology of coronavirus disease 2019: Neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology. 2021;29:939–963. doi: 10.1007/s10787-021-00806-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00806-x</ArticleId><ArticleId IdType="pmc">PMC8021940</ArticleId><ArticleId IdType="pubmed">33822324</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2023;401:e21–e33. doi: 10.1016/S0140-6736(23)00810-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00810-3</ArticleId><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., Hu P., GuO L., Liu M., Xu J., et al. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet. 2021;398:747–758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A.V., van Zon S.K.R., Olde Hartman T.C., Rosmalen J.G.M. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452–461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S.J., Martin E.M., Reuken P.A., Scholcz A., Ganse-Dumrath A., Srowig A., Utech I., Kozik V., Radscheidt M., Brodoehl S., et al. Long COVID is associated with severe cognitive slowing: A multicentre cross-sectional study. Eclinicalmedicine. 2024;68:102434. doi: 10.1016/j.eclinm.2024.102434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2024.102434</ArticleId><ArticleId IdType="pmc">PMC10839583</ArticleId><ArticleId IdType="pubmed">38318123</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Azor A., Atchison C., render W., Hellyer P.J., Giunchiglia V., Husain M., Cooke G.S., Cooper E., Lound A., et al. Cognition and Memory after COVID-19 in a Large Community Sample. N. Engl. J. Med. 2024;390:806–818. doi: 10.1056/NEJMoa2311330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2311330</ArticleId><ArticleId IdType="pmc">PMC7615803</ArticleId><ArticleId IdType="pubmed">38416429</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The immunology of long, COVID. Nat. Rev. Immunol. 2023;23:618–634. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Salazar B., Holwerda M., Studle C., Piragyte I., Mercader N., Engelhardt B., Rieben R., Döring Y. COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences. Front. Cell Dev. Biol. 2022;10:824851. doi: 10.3389/fcell.2022.824851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.824851</ArticleId><ArticleId IdType="pmc">PMC8887620</ArticleId><ArticleId IdType="pubmed">35242762</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Batlle D., Wysocki J., Satchell K. Soluble angiotensin-converting enzyme 2: A potential approach for coronavirus infection therapy? Clin. Sci. 2020;134:543–545. doi: 10.1042/CS20200163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200163</ArticleId><ArticleId IdType="pubmed">32167153</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Escobar A., Jimenez-Valero S., Galeote G., Jurado-Román A., García-Rodríguez J., Moreno R. The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: New insights for heart failure and COVID-19. Heart Fail. Rev. 2021;26:961–971. doi: 10.1007/s10741-020-10066-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-020-10066-6</ArticleId><ArticleId IdType="pmc">PMC7786157</ArticleId><ArticleId IdType="pubmed">33404999</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>